Pay in 4 interest-free payments of $11.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
1S xenograft by IP injection at 50 mg/kg (5 days a week)
1203494-49-8
1 μM canertinib inhibits ErbB1-3 receptor phosphorylation with a concomitant decrease of Akt-
an EC50 value comparable to that of our previously described benzoxoloazepinolone
507: a subnanomolar human beta 3 adrenergic receptor agonist
BI-9564 - BRD9 Bromodomain Inhibitor. CAS# 1883429-22-8 size:2 mg solid 1S xenograft by IP injectionBI 9564, CAS No. 1883429 22 8, is a potent and selective inhibitor of BRD9 and BRD7 bromodomains (Kds = 14. 1 and 239 nM; IC50s = 75 nM and 3. 4 M, respectively). BI 9564 is useful in further exploring BRD9 bromodomain biology in both in vitro and in vivo settings. Selective inhibitors of bromodomain containing protein 9 (BRD9) may have therapeutic potential in the treatment of human malignancies and inflammatory diseases. Product information CAS
US$ 1625.00
US$ 825.00
US$ 100.00
US$ 100.00
US$ 30.00
US$ 50.00
US$ 375.00
US$ 30.00
US$ 450.00
US$ 40.00
US$ 32.00
US$ 10.00
US$ 375.00
US$ 20.00
US$ 300.00
US$ 247.50
US$ 4375.00